Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates ...
SAN FRANCISCO--(BUSINESS WIRE)--In 2024, Unlearn ® achieved key milestones in advancing AI to eliminate trial and error in medicine. From securing $50M in Series C ...
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced it scored $50 million in Series C funding, bringing its total raise to more than $130 million. Altimeter ...
Unlearn seems to have retained a lesson or two about fundraising: The digital twin developer announced this week that it has raised another $50 million, echoing its last funding round two years ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results